CT
UTHR icon

Clearstead Trust’s United Therapeutics UTHR Stock Holding History

Clearstead Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Hold
2
– – ﹤0.01% 928
2026
Q1 		$1.19K Hold
2
– – ﹤0.01% 926
2025
Q4 		$975 Buy
+2
New +$931 ﹤0.01% 949

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Clearstead Trust's UTHR Position: Q2 2026 in Review

Clearstead Trust held its United Therapeutics (UTHR) position steady in Q2 2026 at 2 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Clearstead Trust first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.19K in Q1 2026. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Clearstead Trust held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
  • Clearstead Trust left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #928 holding.
  • Clearstead Trust first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Clearstead Trust's United Therapeutics position peaked at $1.19K in Q1 2026.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.